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ABSTRACT 
Upon activation, T-cells increase the uptake of glucose and glutamine to 
build the constituents of proliferating effectors. However, tumor and 
infected cells compete for the same nutrients. Several observations are 
consistently indicating that activated T-cells overcome this situation by 
engaging catabolic pathways. Here I discuss how these observations are 
reconciled with T-cells’ need of anabolic processes during activation. 
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According to current paradigms, resting T-cells, once activated, shift 
from a catabolic to an anabolic metabolism which is necessary to sustain 
their growth, proliferation and effector functions. This energetic switch is 
controlled by mTOR, whose activation leads to induction of downstream 
processes including glutaminolysis and aerobic glycolysis—two pathways 
that provide intermediates needed for the biosynthesis of new nucleotides, 
amino acids and fatty acids (FA) for proliferating T-cells. To fuel this 
biosynthetic machinery, T-cells cannot just rely on internal nutrient stores. 
For instance, upon T-cell activation, new FAs are supplied for the cell not 
only via upregulation of FA synthesis (FAS) and lysis of triacylglycerols, 
but also by the cell’s increased uptake of extracellular FAs [1,2]. Similarly, 
both glucose and glutamine intake are induced upon TCR triggering. 
However, T-cell responses are deeply influenced by both the organism 
nutritional status and the local microenvironment. Protective immunity is 
indeed disrupted in both undernourished and overnourished individuals 
due to changes in circulating hormones and metabolites [3–5], a 
phenomenon exacerbated by the infections themselves, with further 
negative consequences on disease control [6,7]. In addition, T-cell 
responses take place at effector sites usually limited in nutrients [8,9]. For 
instance, infections often alter levels of certain metabolites in infected 
cells, in other immune cells interacting with lymphocytes or even 
systemically [7,10–14]. Additionally, at both infection and tumor sites, a 
huge competition for glucose and glutamine exists [8], and a high 
glycolytic rate in cancer cells has been shown to correlate with the low 
effector functions of intratumor T-cells [15]. The tumor micro-
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environment is also poor of co-stimulatory molecules, further preventing 
the metabolic switch in activated T-cells [16]. T-cells have shown to cope 
with these situations by shifting from glycolysis to glutaminolysis [14] and 
vice versa [17]. Conversely, tumor cells may not share the same metabolic 
plasticity. For instance, glycolysis inhibition blocks lactate secretion by 
tumor cells and augments T-cell infiltration and effector functions as well 
the effectiveness of checkpoint inhibitors [18]. Effector T-cells react to 
glucose withdrawal by boosting glutamine metabolism for ATP 
generation—a process controlled by the adenosine monophosphate-
activated protein kinase (AMPK), whose activity is regulated by the 
AMP/ATP ratio [14]. Similarly, while glutaminolysis blocking disables 
tumor cells, it may improve T-cell functionality [17] by prompting the 
usage of FAs and glucose metabolism derivatives to fuel the tricarboxylic 
acid cycle and generate ATP [17]. High ATP levels will then down-modulate 
the AMPK activity [17] finally enabling the initiation of anabolic processes 
(which are inhibited by AMPK). Therefore, T cells activated in low nutrient 
conditions seem to alternate cycles of ATP generation (supported by 
AMPK) with cycles of anabolic processes (requiring AMPK inactivation).  
Calorie restriction (CR) represents an interesting model to study T-cell 
behavior in low nutrient settings, as it enhances the responsiveness of T-
cells and reduces their terminal differentiation. In addition, CR induces 
autophagy [19,20] and prompts T-cells to migrate into the bone marrow 
(BM), where they survive in a lipid-rich environment [21–24]. As CR affects 
both metabolite [25] and hormone [21] levels, the exact contribution of 
each single factor is difficult to define. Nevertheless, lipid usage and 
autophagy seem to be important pathways exploited by T-cells under CR. 
Notably, the induction of autophagy and lipid catabolism in activated T-
cells may seem counter-intuitive, as both pathways are inhibited by mTOR. 
Autophagy induction is crucial for the survival of cells (including 
lymphocytes) during starvation or hypoxia [26–28] and for the 
maintenance of memory T-cells [26,27,29]. However, some recent 
publications have also described a role for autophagy in the stimulation of 
early-differentiated CD8+ T-cells, where it is induced simultaneously with 
mTOR triggering [30,31]. More than that, mTOR activity itself seems 
supported by autophagosomes [32]. In this respect, an interesting 
observation comes from the comparison of naïve with central memory T-
cells. Both subsets reside in secondary lymphoid organs and have minimal 
energetic requirements. However, naïve T-cells display a lower basal 
nutrient uptake and thus suffer, de facto, from a limited access to 
nutrients. Nonetheless, they can compensate for this disadvantage by 
upregulating both mTOR and autophagy to levels higher than those of 
central memory T-cells [31]. Therefore, autophagy seems to provide 
additional energy to T-cells activated during nutrient deficiency. Similarly, 
FAO is considered the central energy source for resting T-cells [33], while 
TCR stimulation induces its opposite pathway, FAS. However, the 
induction of FAO during the priming of naïve CD8+ T-cell has been shown 
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to boost the functionality of new effectors without altering their 
proliferation rate [31], especially during nutrient deficiency within tumors 
[34–36]. Indeed, it has been demonstrated in both tumor and persistent 
infection models that T-cells activated in a glucose-deprived and hypoxic 
microenvironment show enhanced expression of inhibitory checkpoints 
[34,37] associated with a reduced glycolysis and compensated by an 
increased FAO [34,38]. While the use of immune checkpoint blockers may 
in part reprogram T-cell metabolism [37,38], the simultaneous activation 
of FAO (through drugs) helps T-cells to overcome their reliance on glucose 
and improves their effector functions and the effectiveness of anti-PD-1 
therapy [34–36]. These pieces of evidence show that metabolic pathways 
generally used by resting T-cells may be important upon activation to 
overcome poor nutrient availability. Nonetheless, it is unclear how 
proliferating T-cells, which exploit an mTOR-dependent anabolic 
metabolism, may be sustained by autophagy and FAO (which are rather 
inhibited by mTOR). The answer may derive in part from the observation 
of the bioenergetic features of resting memory T-cells. Indeed, despite the 
fact that they are considered highly reliant on FAO, their FA uptake is 
usually low. Quiescent T-cells are thought to themselves synthesize the FAs 
that will then be oxidized, alternating FAS and FAO [39]. FAS utilizes ATP, 
increasing the AMP/ATP ratio and inducing AMPK activity. AMPK then 
inhibits FAS and stimulates FAO, which generates ATP. This decreases the 
AMP/ATP ratio, switching off AMPK so that FAS may begin again, We 
cannot exclude that a similar cycle may occur during nutrient deprivation 
and that, in this way, AMPK may also control the mTOR/autophagy balance 
(e.g., alternating cycles of AMPK and mTOR activity). 
In conclusion, several independent observations highlight that T-cells 
may meet their energetic demand during nutrient deficiency by using 
AMPK-controlled pathways such as autophagy and FAO [40]. However, to 
reconcile their metabolic requirements and growth needs, T-cells may be 
forced to alternate catabolic and anabolic processes in order to make up 
for the lack of biomolecules and construct the building blocks of 
proliferating cells, respectively. To finally translate immunometabolic 
studies into clinical practices, it will be crucial to finely dissect the kinetics 
of the different metabolic pathways engaged by T-cells in low nutrient 
settings (e.g., during infections, in tissues, during systemic metabolic 
alterations). Indeed, so far it is not yet clear whether the shift toward 
catabolic processes, enforced in nutrient-deprived settings, should be 
favored, to limit the competition for glucose [34–36], or should be rather 
counteracted, to improve T-cell glycolytic rate [41,42]. In addition, we are 
still far from knowing how different T-cell subpopulations react to poor 
biomolecule availability, and this constitutes a great limitation 
considering the huge amount of conditions, such as infections and age, 
that unbalance the proportion of early and late differentiated T-cell 
subsets [43–46]. It is therefore important that, when considering the use of 
molecules capable of affecting T-cell metabolism, such 
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immunotherapeutic strategies should not desynchronize the bioenergetic 
processes of lymphocytes and thus undermine their capability to 
overcome nutrient deprivation.  
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